Collective Strategies to Enhance Proportionate Enrollment

Topics Included: Access to Clinical Trials, Patient Engagement, Recruitment, Regulatory Submissions + Approvals, Site Planning

The Collective Strategies to Enhance Proportionate Enrollment project focuses on improving accountability, clarity, and communication across clinical trials partner groups to support more effective recruitment, enrollment, and retention practices. This effort seeks to understand and address the challenges, expectations, and needs of each group involved in clinical trials, including contract research organizations, patient organizations, sites, and sponsors.

By fostering action-focused and unified engagement throughout the clinical trials process, the project aims to identify practical solutions that help plan, design, and execute trials better positioned to recruit and retain participants who reflect the epidemiology and scientific evidence of the disease under study. These efforts will support the generation of reliable, relevant, and robust data to inform the development of safe and effective medical products for all populations.

Key Takeaways

Resources

Access to Clinical Trials | CTTI News

New CTTI Project Aims to Identify Challenges and Solutions to Strengthen Proportionate Enrollment in Clinical Trials

In December 2024, CTTI launched the Collective Strategies to Enhance Proportionate Enrollment project to improve communication, accountability and clarity across clinical trial partner groups.

Formats

Stage of Trial

New CTTI Project Aims to Identify Challenges and Solutions to Strengthen Proportionate Enrollment in Clinical Trials 

CTTI News | December 3, 2024

Topics Included: Access to Clinical Trials

In December 2024, CTTI launched the Collective Strategies to Enhance Proportionate Enrollment project to improve communication, accountability and clarity across clinical trial partner groups. The project focuses on addressing persistent challenges that hinder the enrollment and retention of participants who reflect the populations most affected by the disease under study. 

Through this effort, CTTI aims to foster unified, action-focused collaboration among sponsors, contract research organizations, sites, patient organizations and other key groups involved in clinical research. By strengthening coordination and aligning expectations, the project will help identify practical strategies to improve how trials are planned and executed. 

To inform this work, CTTI is gathering evidence through qualitative methods, including interviews with individuals involved in clinical trial operations, to better understand group-specific needs and challenges. These insights will shape a set of recommendations and tools that clarify roles, outline implementation considerations and support proportionate enrollment across the trial lifecycle. 

Ultimately, this project will support the generation of high-quality, reliable data and the development of medical products that are safe and effective for all populations. These efforts align with CTTI’s Transforming Trials 2030 vision to create a more efficient, patient-centered and representative clinical trial enterprise.